BRPI1014574A2 - Compostos inéditos de imitadores de ligação revesa, método para fabricar os mesmos e uso destes - Google Patents
Compostos inéditos de imitadores de ligação revesa, método para fabricar os mesmos e uso destesInfo
- Publication number
- BRPI1014574A2 BRPI1014574A2 BRPI1014574-5A BRPI1014574A BRPI1014574A2 BR PI1014574 A2 BRPI1014574 A2 BR PI1014574A2 BR PI1014574 A BRPI1014574 A BR PI1014574A BR PI1014574 A2 BRPI1014574 A2 BR PI1014574A2
- Authority
- BR
- Brazil
- Prior art keywords
- mimics
- manufacturing
- reverse link
- unpublished
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65611—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090032937 | 2009-04-15 | ||
| PCT/KR2010/002306 WO2010120112A2 (en) | 2009-04-15 | 2010-04-14 | Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014574A2 true BRPI1014574A2 (pt) | 2015-08-25 |
Family
ID=42981437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014574-5A BRPI1014574A2 (pt) | 2009-04-15 | 2010-04-14 | Compostos inéditos de imitadores de ligação revesa, método para fabricar os mesmos e uso destes |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100267672A1 (pt) |
| EP (1) | EP2419430A4 (pt) |
| JP (1) | JP5657642B2 (pt) |
| KR (1) | KR101692921B1 (pt) |
| CN (1) | CN102459271B (pt) |
| AU (1) | AU2010237633B2 (pt) |
| BR (1) | BRPI1014574A2 (pt) |
| CA (1) | CA2758904C (pt) |
| IL (1) | IL215732A (pt) |
| MX (1) | MX340424B (pt) |
| RU (1) | RU2515983C2 (pt) |
| SG (1) | SG175045A1 (pt) |
| WO (1) | WO2010120112A2 (pt) |
| ZA (1) | ZA201107357B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2533048A4 (en) | 2010-02-03 | 2013-08-21 | Prism Biolab Co Ltd | CONNECTION TO THE BINDING OF NATURALLY OBTAINING DENATURED PROTEINS AND METHOD FOR SCREENING AFTER THIS CONNECTION |
| EP2628741B1 (en) * | 2010-10-14 | 2015-10-07 | JW Pharmaceutical Corporation | Novel compound of a reverse-turn mimetic and a production method and use therefor |
| CN103517904A (zh) * | 2011-02-25 | 2014-01-15 | 株式会社棱镜制药 | α-螺旋模拟物和与其相关的方法 |
| ES2577863T3 (es) | 2011-08-09 | 2016-07-19 | Jw Pharmaceutical Corporation | Composición para la prevención y el tratamiento del cáncer de pulmón de células no pequeñas, que contiene derivados de pirazino-triazina |
| US9353119B2 (en) | 2011-08-09 | 2016-05-31 | Jw Pharmaceutical Corporation | Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives |
| KR20140053952A (ko) * | 2011-08-26 | 2014-05-08 | 제이더블유중외제약 주식회사 | 피라지노-트리아진 유도체를 포함하는 조성물 |
| CN105829331A (zh) * | 2013-09-11 | 2016-08-03 | 株式会社棱镜制药 | 生产吡嗪并[2，1-c][1，2，4]三嗪化合物的方法 |
| CN106029076B (zh) | 2013-11-18 | 2019-06-07 | 福马疗法公司 | 作为bet溴域抑制剂的苯并哌嗪组合物 |
| TWI742513B (zh) | 2013-11-18 | 2021-10-11 | 美商弗瑪治療公司 | 作為bet溴域抑制劑之四氫喹啉組成物 |
| US9174998B2 (en) * | 2013-12-25 | 2015-11-03 | Eisai R&D Management Co., Ltd. | (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound |
| CA2988707C (en) | 2015-06-16 | 2023-10-10 | Eisai R&D Management Co., Ltd. | Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer |
| JP6126319B1 (ja) | 2015-06-23 | 2017-05-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | （６Ｓ，９ａＳ）−Ｎ−ベンジル−６−［（４−ヒドロキシフェニル）メチル］−４，７−ジオキソ−８−（｛６−［３−（ピペラジン−１−イル）アゼチジン−１−イル］ピリジン−２−イル｝メチル）−２−（プロプ−２−エン−１−イル）−オクタヒドロ−１Ｈ−ピラジノ［２，１−ｃ］［１，２，４］トリアジン−１−カルボキサミド化合物の結晶 |
| US11292791B2 (en) | 2017-09-15 | 2022-04-05 | Forma Therapeutics, Inc. | Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors |
| US10870648B2 (en) | 2018-06-29 | 2020-12-22 | Forma Therapeutics, Inc. | Inhibiting CREB binding protein (CBP) |
| KR20210153908A (ko) * | 2020-06-11 | 2021-12-20 | 제이더블유중외제약 주식회사 | 코로나바이러스감염증-19(covid-19) 치료용 조성물 |
| KR20220000460A (ko) | 2020-06-26 | 2022-01-04 | 제이더블유중외제약 주식회사 | 폐섬유화증 치료용 조성물 |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US559184A (en) * | 1896-04-28 | Eli marshall | ||
| US5475085A (en) * | 1991-02-07 | 1995-12-12 | Molecumetics, Ltd. | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| JPH06505486A (ja) * | 1991-02-07 | 1994-06-23 | モレキュメティクス，リミティド | βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド |
| JPH07509723A (ja) | 1992-08-06 | 1995-10-26 | モレキュメティクス，リミティド | 反転型ターンの立体配座的に拘束されたミメティックスと前者を含有するペプチド |
| US5446128A (en) * | 1993-06-18 | 1995-08-29 | The Board Of Trustees Of The University Of Illinois | Alpha-helix mimetics and methods relating thereto |
| US5693325A (en) * | 1994-03-15 | 1997-12-02 | Molecumetics, Ltd. | Peptide vaccines and methods relating thereto |
| US6020331A (en) * | 1995-03-24 | 2000-02-01 | Molecumetics, Ltd. | β-sheet mimetics and use thereof as protease inhibitors |
| US6245764B1 (en) * | 1995-03-24 | 2001-06-12 | Molecumetics Ltd. | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| US5929237A (en) * | 1995-10-27 | 1999-07-27 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| US6184223B1 (en) * | 1995-10-27 | 2001-02-06 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| US6013458A (en) * | 1995-10-27 | 2000-01-11 | Molecumetics, Ltd. | Reverse-turn mimetics and methods relating thereto |
| US5840833A (en) * | 1995-10-27 | 1998-11-24 | Molecumetics, Ltd | Alpha-helix mimetics and methods relating thereto |
| US6117896A (en) * | 1997-02-10 | 2000-09-12 | Molecumetics Ltd. | Methods for regulating transcription factors |
| US6451972B1 (en) * | 1998-11-16 | 2002-09-17 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| US7192494B2 (en) * | 1999-03-05 | 2007-03-20 | Applied Materials, Inc. | Method and apparatus for annealing copper films |
| US6294525B1 (en) | 1999-09-01 | 2001-09-25 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| US6872825B2 (en) * | 1999-12-21 | 2005-03-29 | The Procter & Gamble Company | Peptide β-turn mimetic compounds and processes for making them |
| DE10005631A1 (de) * | 2000-02-09 | 2001-08-23 | Max Planck Gesellschaft | Arginin-Mimetika als Faktor X¶a¶-Inhibitoren |
| ES2310215T3 (es) * | 2001-10-12 | 2009-01-01 | Choongwae Pharma Corporation | Estructuras mimeticas de giro inverso y metodo relacionado. |
| US7232822B2 (en) * | 2001-10-12 | 2007-06-19 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US20040072831A1 (en) * | 2001-10-12 | 2004-04-15 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US7671054B1 (en) * | 2001-10-12 | 2010-03-02 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US8080657B2 (en) * | 2001-10-12 | 2011-12-20 | Choongwae Pharma Corporation | Compounds of reverse turn mimetics and the use thereof |
| US7566711B2 (en) * | 2001-10-12 | 2009-07-28 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US7576084B2 (en) * | 2001-10-12 | 2009-08-18 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
| US6762185B1 (en) * | 2002-03-01 | 2004-07-13 | Choongwae Pharma Corporation | Compounds useful for treatment of cancer, compositions containing the same, and methods of their use |
| CA2537099A1 (en) * | 2003-08-28 | 2005-03-10 | Choongwae Pharma Corporation | Modulation of .beta.-catenin/tcf activated transcription |
| US7563825B1 (en) * | 2005-03-18 | 2009-07-21 | Choongwae Pharma Corporation | Modulation of beta-catenin coactivator interactions to effect stem cell growth or differentiation |
| KR101486490B1 (ko) * | 2005-11-08 | 2015-01-27 | 제이더블유중외제약 주식회사 | α-헬릭스 유사체 및 암 줄기세포의 치료에 관한 방법 |
| KR20090026302A (ko) * | 2006-05-30 | 2009-03-12 | 주식회사 중외제약 | 줄기세포 분화의 유도 또는 억제를 위한 조성물 |
-
2010
- 2010-04-14 EP EP10764651A patent/EP2419430A4/en not_active Withdrawn
- 2010-04-14 WO PCT/KR2010/002306 patent/WO2010120112A2/en active Application Filing
- 2010-04-14 CA CA2758904A patent/CA2758904C/en active Active
- 2010-04-14 JP JP2012505818A patent/JP5657642B2/ja active Active
- 2010-04-14 BR BRPI1014574-5A patent/BRPI1014574A2/pt active IP Right Grant
- 2010-04-14 US US12/759,854 patent/US20100267672A1/en not_active Abandoned
- 2010-04-14 AU AU2010237633A patent/AU2010237633B2/en active Active
- 2010-04-14 MX MX2011010765A patent/MX340424B/es active IP Right Grant
- 2010-04-14 SG SG2011072147A patent/SG175045A1/en unknown
- 2010-04-14 CN CN201080026459.9A patent/CN102459271B/zh active Active
- 2010-04-14 KR KR1020117026683A patent/KR101692921B1/ko active IP Right Grant
- 2010-04-14 RU RU2011146146/04A patent/RU2515983C2/ru active
-
2011
- 2011-10-07 ZA ZA2011/07357A patent/ZA201107357B/en unknown
- 2011-10-11 IL IL215732A patent/IL215732A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2515983C2 (ru) | 2014-05-20 |
| IL215732A0 (en) | 2012-01-31 |
| CN102459271B (zh) | 2014-07-02 |
| CA2758904C (en) | 2017-04-04 |
| AU2010237633A1 (en) | 2011-10-27 |
| KR101692921B1 (ko) | 2017-01-05 |
| WO2010120112A2 (en) | 2010-10-21 |
| SG175045A1 (en) | 2011-11-28 |
| CN102459271A (zh) | 2012-05-16 |
| KR20120028877A (ko) | 2012-03-23 |
| MX2011010765A (es) | 2012-02-08 |
| RU2011146146A (ru) | 2013-05-20 |
| EP2419430A2 (en) | 2012-02-22 |
| ZA201107357B (en) | 2012-07-25 |
| CA2758904A1 (en) | 2010-10-21 |
| MX340424B (es) | 2016-07-08 |
| EP2419430A4 (en) | 2012-10-31 |
| AU2010237633B2 (en) | 2015-09-17 |
| IL215732A (en) | 2014-08-31 |
| US20100267672A1 (en) | 2010-10-21 |
| JP5657642B2 (ja) | 2015-01-21 |
| WO2010120112A3 (en) | 2011-03-31 |
| JP2012524061A (ja) | 2012-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1014574A2 (pt) | Compostos inéditos de imitadores de ligação revesa, método para fabricar os mesmos e uso destes | |
| BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
| BRPI0923748A2 (pt) | Método para a preparação de dióis | |
| BRPI1007867A2 (pt) | anticorpos para troponina i e método s de uso para os mesmos | |
| BRPI1010774A2 (pt) | método de uso de particulados. | |
| BRPI1006141A2 (pt) | composições de anticorpo modificado, métodos para preparar e usar as mesmas | |
| BRPI0812073A2 (pt) | Laminado para moldagem de encaixe e método de sua fabricação, e moldagem de encaixe e método de sua fabricação | |
| BRPI0918359A2 (pt) | composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto | |
| UY33094A (es) | Procedimiento para la preparacion de dronedarona | |
| BRPI0917145A2 (pt) | Método para fabricar biocombustíveis | |
| BRPI0917129A2 (pt) | método de fabricação de fralda | |
| BRPI1008484A2 (pt) | codificador, decodificador e método para os mesmos | |
| BRPI1006633A2 (pt) | bolo liofilizado, metodo para a fabricação de um bolo liofilizado e uso de bolo liofilizado | |
| BRPI0812818A2 (pt) | Turbo-reator para aeronave | |
| BRPI0911815A2 (pt) | estrutura de multifilme, estrutura de envelope feita de uma estrutura de multifilme, uso de uma estrutura de multifilme e processo para preparar uma estrutura de multifilme | |
| BRPI1014035A2 (pt) | método para contracepção. | |
| BRPI1007397A2 (pt) | misturas de borrachas, método para a fabricação das misturas de borrachas e seu uso | |
| BR112012002361A2 (pt) | composição de graxa sem hidróxido, método para a fabricação de uma composição de graxa, e, uso de uma composição de graxa | |
| BR112012003571A2 (pt) | método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante. | |
| BRPI1014262A2 (pt) | anticorpos específicos para caderina-17 | |
| BRPI0921399A2 (pt) | composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante | |
| BRPI0820878A2 (pt) | fuselagem com atenuação acústica para aeronave | |
| BRPI0924393A2 (pt) | lipopolissacarídeo de ochrobactrum intermedium lmg3306, método para o preparo do lipopolissacarídeo, e, composição imunoestimulante | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| BRPI0920862A2 (pt) | composição, método para fabricação da mesma, e uso da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B65X | Notification of requirement for priority examination of patent application | ||
| B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/04/2010, OBSERVADAS AS CONDICOES LEGAIS. |